Literature DB >> 14553958

Serum potassium and stroke risk among treated hypertensive adults.

Nicholas L Smith1, Rozenn N Lemaitre, Susan R Heckbert, Robert C Kaplan, David L Tirschwell, W T Longstreth, Bruce M Psaty.   

Abstract

BACKGROUND: In prospective studies, hypokalemia has been shown to be associated with a subsequent increase in stroke risk in treated hypertensive adults after 4 to 16 years of follow-up. Stroke risk associated with more recent assessments of hypokalemia has not been examined.
METHODS: We used data from an on-going, population-based, case-control study of incident stroke at Group Health Cooperative (GHC). Cases were treated hypertensive adults, 30 to 79 years old, who sustained an incident ischemic or hemorrhagic stroke between July 1989 and December 2000. Controls were GHC members without a history of stroke who met same inclusion criteria as cases. Serum potassium (K(+)) levels were collected from GHC laboratory database. Hypokalemia (< or =3.4 mM/L) was defined using the most recent serum K(+) measure in the year before the index date (event date for cases; random date within calendar year of identification for controls). Multivariate logistic regression estimated the relative risk of ischemic and hemorrhagic stroke.
RESULTS: Among 593 ischemic and 125 hemorrhagic stroke cases, and 2397 controls, few subjects were hypokalemic: 3%, 6%, and 2%, respectively. Using the normal range of serum K(+) as a reference (3.5 to 5.0 mM/L), hypokalemia was associated with an elevated risk of ischemic (odds ratio [OR]: 2.04; 95% confidence interval [CI]: 1.14-3.64) and hemorrhagic stroke (OR: 3.29; 95% CI: 1.45-7.48) in adjusted analyses. Associations were not modified by diuretic use.
CONCLUSIONS: In adults with treated hypertension, hypokalemia in the year before a stroke was associated with an increased risk of incident ischemic and hemorrhagic stroke independent of diuretic use when compared to normal serum K(+) levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553958     DOI: 10.1016/s0895-7061(03)00983-x

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Racial and Ethnic Differences in Mortality Associated with Serum Potassium in Incident Peritoneal Dialysis Patients.

Authors:  Rieko Eriguchi; Yoshitsugu Obi; Melissa Soohoo; Connie M Rhee; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Elani Streja
Journal:  Am J Nephrol       Date:  2019-09-13       Impact factor: 3.754

2.  Enriching the Study Population for Ischemic Stroke Therapeutic Trials Using a Machine Learning Algorithm.

Authors:  Jenish Maharjan; Yasha Ektefaie; Logan Ryan; Samson Mataraso; Gina Barnes; Sepideh Shokouhi; Abigail Green-Saxena; Jacob Calvert; Qingqing Mao; Ritankar Das
Journal:  Front Neurol       Date:  2022-01-25       Impact factor: 4.086

3.  Incidence and Determinants of Piperacillin/Tazobactam-Associated Hypokalemia: A Retrospective Study.

Authors:  Heenam Seo; Eunyoung Kim
Journal:  Antibiotics (Basel)       Date:  2022-08-22

4.  SARS-COV-ATE risk assessment model for arterial thromboembolism in COVID-19.

Authors:  Pin Li; Yi Lee; Qasim Jehangir; Chun-Hui Lin; Geetha Krishnamoorthy; Anupam A Sule; Abdul R Halabi; Kiritkumar Patel; Laila Poisson; Girish B Nair
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

5.  Association of Dyskalemias with Ischemic Stroke in Advanced Chronic Kidney Disease Patients Transitioning to Dialysis.

Authors:  Ankur A Dashputre; Keiichi Sumida; Fridtjof Thomas; Justin Gatwood; Oguz Akbilgic; Praveen K Potukuchi; Yoshitsugu Obi; Miklos Z Molnar; Elani Streja; Kamyar Kalantar Zadeh; Csaba P Kovesdy
Journal:  Am J Nephrol       Date:  2021-07-21       Impact factor: 4.605

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.